NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET 2019-2028

MARKET OUTLOOK
Triton's report on the injectable drug delivery market in the Middle East and Africa states that this industry is expected to grow with a CAGR of 9.63% in the forecast period 2019-2028. Turkey, the UAE, Saudi Arabia, South Africa, and Rest of MEA together shape the market in this region.
Factors such as the rise in the incidence of chronic diseases, growth in the pharmaceutical sector, and advancements in injectable drug delivery technology are fueling the growth of the market in this region. In 2018, Israeli scientists developed advanced technology for drug delivery, which is used with a long-wave light. This light is used for releasing drugs in a highly targeted, non-invasive method. The non-invasive method prohibits the drugs in the patient’s body from randomly dispersing.
This novel technology was developed by Israeli Ph.D. student Alona Shagan and Boaz Mizrahi, Assistant Professor at the Israel Institute of Technology. This advancement in drug delivery technology is expected to augment its adoption, and, in turn, contribute to the global efforts for developing smart systems for drug delivery. They can significantly target the specific body part that is affected by cancer, bypassing healthy tissue, and thereby contribute to the treatment of these diseases. It can thus be said that the injectable drug delivery market in Rest of MEA is on a growth path.
COMPETITIVE OUTLOOK
The notable players in this market include Baxter International Inc, Becton Dickinson and Company (BD), Pfizer Inc, Schott AG, Eli Lilly and Company, Injex, Novo Nordisk A/S, and Gerresheimer.

TABLE OF CONTENTS
1. MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES MODEL
2.2.1. THREAT OF NEW ENTRANT
2.2.2. THREAT OF SUBSTITUTE
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. INTENSITY OF COMPETITIVE RIVALRY
2.3. KEY INSIGHT
2.4. KEY BUYING CRITERIA
2.5. MARKET ATTRACTIVENESS INDEX
2.6. MARKET DRIVERS
2.6.1. INCREASING GERIATRIC POPULATION
2.6.2. TECHNOLOGICAL ADVANCEMENT
2.6.3. GROWING OCCURRENCE OF AUTOIMMUNE DISEASES
2.7. MARKET RESTRAINTS
2.7.1. HIGH MANUFACTURING COST OF INJECTABLE DRUG DELIVERY SYSTEMS
2.8. MARKET OPPORTUNITIES
2.8.1. DEVELOPMENT OF BETTER INJECTABLE SYSTEMS
2.8.2. INCREASE IN HEALTHCARE EXPENDITURE
2.9. MARKET CHALLENGES
2.9.1. DEVELOPMENTS IN THE ALTERNATE DRUG DELIVERY SYSTEMS
2.9.2. STRINGENT REGULATIONS
3. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY DEVICE TYPE
3.1. PEN INJECTOR
3.2. AUTO?INJECTOR
3.3. NEEDLE-FREE INJECTOR
3.4. PREFILLED SYRINGE
4. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION
4.1. SUBCUTANEOUS
4.2. INTRAMUSCULAR
4.3. INTRAVENOUS (IV)
4.4. OTHER ROUTE OF ADMINISTRATION
5. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY END-USER
5.1. CLINICS/ PHYSICIAN OFFICES
5.2. AMBULATORY CARE
5.3. HOSPITAL
5.4. HOME-BASED
5.5. OTHER END-USERS
6. INJECTABLE DRUG DELIVERY MARKET – MIDDLE EAST AND AFRICA
6.1. COUNTRY ANALYSIS
6.1.1. SAUDI ARABIA
6.1.2. TURKEY
6.1.3. UNITED ARAB EMIRATES
6.1.4. SOUTH AFRICA
6.1.5. REST OF MIDDLE EAST & AFRICA
7. COMPANY PROFILES
7.1. BAXTER INTERNATIONAL INC
7.2. BECTON DICKINSON AND COMPANY (BD)
7.3. ELCAM MEDICAL
7.4. ELI LILLY AND COMPANY
7.5. GERRESHEIMER
7.6. INJEX
7.7. NOVARTIS AG
7.8. NOVO NORDISK A/S
7.9. PFIZER INC
7.10. SANOFI SA
7.11. SCHOTT AG
7.12. TERUMO CORPORATION
7.13. TEVA PHARMACEUTICALS
7.14. WEST PHARMACEUTICALS
7.15. YPSOMED HOLDING AG
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS


LIST OF TABLES
TABLE 1 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY REGION, 2019-2028 ($ MILLION)
TABLE 2 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2028 ($ MILLION)
TABLE 3 DIFFERENT TYPES OF INSULIN PEN INJECTORS
TABLE 4 MARKETED NEEDLE-FREE INJECTORS PRODUCTS
TABLE 5 LYOPHILIZED DRUGS WHICH ARE USED IN PREFILLED SYRINGE
TABLE 6 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 ($ MILLION)
TABLE 7 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)
TABLE 8 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

LIST OF FIGURES
FIGURE 1 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)
FIGURE 2 KEY BUYING IMPACT ANALYSIS
FIGURE 3 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY PEN INJECTOR, 2019-2028 ($ MILLION)
FIGURE 4 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY AUTO?INJECTOR, 2019-2028 ($ MILLION)
FIGURE 5 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY NEEDLE-FREE INJECTOR, 2019-2028 ($ MILLION)
FIGURE 6 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY PREFILLED, 2019-2028 ($ MILLION)
FIGURE 7 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY SUBCUTANEOUS, 2019-2028 ($ MILLION)
FIGURE 8 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY INTRAMUSCULAR, 2019-2028 ($ MILLION)
FIGURE 9 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY INTRAVENOUS, 2019-2028 ($ MILLION)
FIGURE 10 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY OTHER ROUTE OF ADMINISTRATION, 2019-2028 ($ MILLION)
FIGURE 11 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY CLINICS/PHYSICIAN OFFICES, 2019-2028 ($ MILLION)
FIGURE 12 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY AMBULATORY CARE, 2019-2028 ($ MILLION)
FIGURE 13 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY HOSPITAL, 2019-2028 ($ MILLION)
FIGURE 14 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY HOME-BASED, 2019-2028 ($ MILLION)
FIGURE 15 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY OTHER END-USER, 2019-2028 ($ MILLION)
FIGURE 16 SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)
FIGURE 17 TURKEY INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)
FIGURE 18 UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)
FIGURE 19 SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)
FIGURE 20 REST OF MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)